Children's Cancer Group, China
Clinical trials sponsored by Children's Cancer Group, China, explained in plain language.
-
New hope for young hodgkin lymphoma patients: trial aims to boost cure rates, cut radiation
Disease control Recruiting nowThis study is testing a new combination of cancer drugs for children, teens, and young adults (ages 2-35) newly diagnosed with classical Hodgkin lymphoma. The main goal is to improve the rate of early, complete response to treatment, which could allow more patients to avoid radia…
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Breakthrough trial tests better chemo for Kids' cancer
Disease control Recruiting nowThis study compares two different chemotherapy approaches for children with newly diagnosed T-cell lymphoblastic lymphoma, a type of blood cancer. Researchers want to see which method works better at keeping the cancer from coming back while potentially causing fewer side effects…
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for kids with Tough-to-Treat cancer: doubling down on a key drug
Disease control Recruiting nowThis study is testing if using a stronger chemotherapy schedule and giving a targeted drug called rituximab more often and earlier in treatment can help children and teenagers with very aggressive forms of B-cell lymphoma live longer without their cancer coming back. It builds on…
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC